Samil Pharm (000520) — Capital Reinvestment Ratio
Samil Pharm (000520) has a Capital Reinvestment Ratio of 1.33x as of June 2025, meaning it reinvests 1% of its operating cash flow (₩2.44 Billion) in capital expenditures (₩3.26 Billion). See Samil Pharm (000520) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Samil Pharm Capital Reinvestment Ratio (2012–2024)
This chart tracks Samil Pharm's Capital Reinvestment Ratio across 10 annual periods. Check Samil Pharm (000520) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Samil Pharm (2012–2024)
Year-by-year Capital Reinvestment Ratio for Samil Pharm from 2012 to 2024. For live market cap and broader valuation context, see Samil Pharm (000520) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.17x | ₩2.59 Billion | ₩5.61 Billion | ▲ +4.3% |
| 2023 | 2.08x | ₩11.75 Billion | ₩24.39 Billion | ▼ -82.2% |
| 2022 | 11.67x | ₩4.15 Billion | ₩48.48 Billion | ▼ -49.6% |
| 2021 | 23.17x | ₩1.42 Billion | ₩32.83 Billion | ▲ +958.4% |
| 2020 | 2.19x | ₩7.77 Billion | ₩17.02 Billion | ▲ +66.9% |
| 2019 | 1.31x | ₩10.59 Billion | ₩13.89 Billion | ▼ -86.3% |
| 2017 | 9.58x | ₩3.79 Billion | ₩36.33 Billion | ▲ +1112.5% |
| 2016 | 0.79x | ₩5.63 Billion | ₩4.45 Billion | ▼ -2.1% |
| 2015 | 0.81x | ₩2.92 Billion | ₩2.36 Billion | ▲ +112.4% |
| 2012 | 0.38x | ₩5.02 Billion | ₩1.91 Billion | — |